Nastech files nipple fluid aspirator with FDA
This article was originally published in Clinica
Nastech Pharmaceutical Company has submitted to the US FDA its non-invasive device for drawing nipple aspirate fluid samples for breast cancer cytology tests.
You may also be interested in...
Confusion is rife over low UK testing levels to confirm COVID-19 in health care staff and patients, and comparisons with measures taken in similar-sized economies have been unfavorable. Diagnostics manufacturers are not to blame, says the industry.
Jakavi joins the likes of Actemra in targeting the life-threatening immune reaction which is killing acutely ill COVID-19 patients
As China is poised to supply globally medical products to fight coronavirus, a battle to banish its image of poor product quality is on.